Gilead Advancing Access Patient Assistance Program/Medication Assistance Program (PAP/MAP): Sunlenca
Funded
About
The Gilead Advancing Access Patient Assistance Program/Medication Assistance Program (PAP/MAP) offers significant benefits, including free access to the medication Sunlenca for eligible patients. The program is designed to help those who meet specific residency, insurance, and income guidelines, ensuring that patients who need Sunlenca can receive it at no cost. By joining the Gilead Advancing Access Program, patients benefit from comprehensive support and potential cost savings on their essential medication.
Insurance requirements: Underinsured, Uninsured
Enrollment Forms
Enrollment Form
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: Yes
•Activation Required: No
Program Details
•Eligible patients may be able to receive medication at no cost
•HCP should fax completed application form and any supporting documentation to: 8334453234
•HCP and Patients can also enroll online at: https://advancingaccessconsent.iassist.com/
•Proof of residency and income must be provided
•An Advancing Access reimbursement counselor will notify the requestor about the patient’s coverage and benefits, alternate funding options and/or qualification for the PAP
•Patients who meet the eligibility criteria for the PAP will be prequalified for the program
•The program will notify the patient and the prescriber of the prequalified status
•Call 8002262056 Monday through Friday, 9 am to 8 pm EST for more information
Enrollment Forms
Enrollment Form